In this special episode of The Points of CARE, recorded live during the American Diabetes Association's (ADA) 2026 Scientific Sessions in New Orleans, hosts Richard Beaser, MD and Jane Reusch, MD highlight a new symposium on the clinical, social, and economic costs of treating—or not treating—individuals with obesity.

This panel discussion is moderated by Louis J. Aronne, MD, Sanford I. Weill Professor of Metabolic Research at Weill-Cornell Medical College in New York, former president of the Obesity Society, and chair emeritus of the American Board of Obesity Medicine.

Presenters:

• Timothy Dall, MS Managing Director for Life Sciences Consulting at GlobalData

• Melanie R. Jay, MD, Professor of Medicine and Population Health at the New York University Grossman School of Medicine

• Catherine Ferguson, MA, Vice President of Federal Advocacy for the ADA

Featured Articles:

• The Cost of Inaction in Treating Obesity in the U.S. doi.org/10.2337/doci25-0011

• Benefits and Costs of Treating Obesity Among Adults in Commercial Insurance Plans doi.org/10.2337/doci25-0006

• Estimating the Health, Economic, and Social Benefits of Obesity Treatment Using Microsimulation Modeling doi.org/10.2337/doci25-0004

For more on the Cost of Obesity collection, visit diabetesjournals.org/collection/26413/Cost-of-Obesity

To learn more about Diabetes, Obesity, and CardioMetabolic CARE please visit diabetesjournals.org/docm-care. Thank you for listening, and don't forget to subscribe.